was bpc 157 banned Banned: Key Facts on the Latest FDA Decision PEPTIDES: THE 2026 FDA CRACKDOWN
Description
The initial consult was great
Key Mechanistic Differences# The mechanistic distinction is significant: Dihexa promotes structural synaptic plasticity through growth factor signaling (building new connections), while PE-22-28 modulates functional neuronal properties through ion channel blockade (changing how existing neurons fire)
Best For: Advanced formulators who want direct control of peptide concentration
Supports immune defense mechanisms
